Abstract:Ligands in many instances interact with a protein at multiple sites with a range of affinities. In the present study, ligand-protein interaction sites on Human Serum Albumin (HSA) are mapped using the site-identification by ligand competitive saturation (SILCS)-Biologics approach in conjunction with Hydrogen-Deuterium Exchange (HDX)-Mass Spectrometry (MS) experiments. Ligands studied include known HSA binders, Ibuprofen and Ketoprofen, and compounds Arginine, Alanine, Sucrose and Trehalose, excipients used in therapeutic formulations of protein-based drugs. In addition, the impact of excipient binding to HSA on its stability is investigated through temperature-ramp stability studies monitoring solution viscosity. For the studied ligands, interactions that correspond to known drug-binding sites (DS) are identified. These include previously identified Ibuprofen and Ketoprofen interaction sites as well as additional sites and, in the case of the excipients, the ligands are shown to also bind at previously unidentified lower affinity interaction sites, termed excipients sites (ES) with 20 or more sites identified for the studied compounds. HDX-MS titrations were used to determined dissociation constants for a subset of the interaction sites for Ibuprofen, Ketoprofen, Arginine, and Sucrose, which exhibited Kd values in the low micromolar to millimolar range in satisfactory agreement with SILCS-Biologics predicted affinities, validating the computational approach to identify both high and low affinity interaction sites. The stability studies indicate the excipients to offer protection at low excipient-protein ratios up to 66 with destabilization occurring at ratios above 132 with the exception of Sucrose at the t0 timepoint, indicating that the more favorable affinities of Sucrose seen in the SILCS-Biologics and HDX-MS analyses contribute to protein stabilization. These results indicate that ligands can bind to large numbers of interaction sites on proteins, with those interactions having implications for the development of formulations for therapeutic proteins.

How hydrophilic group affects drug–protein binding modes: Differences in interaction between sirtuins inhibitors Tenovin-1/Tenovin-6 and human serum albumin

Evaluation of Molecular Binding Modes on Site Ii of Human Serum Albumin

Molecular Simulations on Dynamic Binding of Ibuprofen Onto Site II of Human Serum Albumin: One Potential Way Analysis

Study of conformational and functional changes caused by binding of environmental pollutant tonalide to human serum albumin

Characterization of interactions of simvastatin, pravastatin, fluvastatin, and pitavastatin with bovine serum albumin: multiple spectroscopic and molecular docking.

Binding behavior of trelagliptin and human serum albumin: Molecular docking, dynamical simulation, and multi-spectroscopy

Spectroscopic and Molecular Docking Studies of Binding Interaction of Gefitinib, Lapatinib and Sunitinib with Bovine Serum Albumin (BSA).

Thermal effects and drugs competition on the palmitate binding capacity of human serum albumin

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.

Effect of Chinese medicine alpinetin on the structure of human serum albumin

Profiling the Interaction between Human Serum Albumin and Clinically Relevant HIV Reverse Transcriptase Inhibitors

Molecular Interaction Studies of Trimethoxy Flavone with Human Serum Albumin

Binding of quercetin and curcumin to human serum albumin in aqueous dimethyl sulfoxide and in aqueous ethanol

Binding of a potential anti-hepatoma drug cis,cis,trans-[Pt(NH3)2Cl2(O2CCH2CH2COOH)-(OCONHC16H33)] with serum albumin – thermodynamic and conformational investigations

Study on the Interaction of Two Quinazoline Derivatives As Novel PI3K/mTOR Dual Inhibitors and Anticancer Agents to Human Serum Albumin Utilizing Spectroscopy and Docking

Mapping the Distribution and Affinities of Ligand Interaction Sites on Human Serum Albumin

Interactions Between Hydroxylated Polycyclic Aromatic Hydrocarbons and Serum Albumins: Multispectral and Molecular Docking Analyses.

Interaction and Binding Kinetics of Different Substituted Pyrazines with HSA: Based on Multispectral, Physiological Activity, and Molecular Dynamics Simulations

Structural Basis of the Drug-binding Specificity of Human Serum Albumin

Deciphering the spectroscopic and thermodynamic aspects of binding of biologically important antioxidants with alkali induced state of human serum albumin

Investigating the interactions of benzoylaconine and benzoylhypacoitine with human serum albumin: Experimental studies and computer calculations